Profil
Dr. Godelieve Verplancke is an Independent Director at Materialise NV.
She is on the Board of Directors at Materialise NV and Fondation contre le Cancer.
Dr. Verplancke was previously employed as an Independent Non-Executive Director by MDxHealth SA, an Independent Director by Quest for Growth NV, a Managing Director by Qaly, a Managing Director by Qaly-Co BV, a Managing Director by BRISTOL MYERS SQUIBB BELGIUM BV, and a Managing Director by Merck & Co., Inc. She also served on the board at Euronext Brussels SA/NV, Europe Hospitals, Imelda Hospital and Stichting Tegen Kanker.
She received her graduate degree from the University of Antwerp, an MBA from the University of Antwerp and a doctorate degree from Katholieke Universiteit Leuven.
Postes actifs de Godelieve Verplancke
| Sociétés | Poste | Début |
|---|---|---|
| MATERIALISE NV | Directeur/Membre du Conseil | 09/06/2015 |
Fondation contre le Cancer
Fondation contre le Cancer Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | - |
Anciens postes connus de Godelieve Verplancke
| Sociétés | Poste | Fin |
|---|---|---|
| MDXHEALTH SA | Directeur/Membre du Conseil | 08/07/2024 |
Qaly | Directeur Général | 01/01/2020 |
Qaly-Co BV | Fondateur | 01/01/2020 |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes medicines | Corporate Officer/Principal | 01/01/2012 |
Formation de Godelieve Verplancke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Euronext Brussels SA/NV
Euronext Brussels SA/NV Investment Banks/BrokersFinance Operates a stock exchange | Finance |
MDxHealth SA
MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Quest for Growth NV
Quest for Growth NV Investment ManagersFinance Functions as a private equity fund | Finance |
Materialise NV
Materialise NV Packaged SoftwareTechnology Services Provides additive manufacturing software and 3D printing services | Technology Services |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes medicines | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stichting Tegen Kanker
Stichting Tegen Kanker Investment Trusts/Mutual FundsMiscellaneous Foundation | Miscellaneous |
Qaly | |
Imelda Hospital | |
Fondation contre le Cancer
Fondation contre le Cancer Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Qaly-Co BV |
















